• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶联合美洛西林作为血液系统恶性肿瘤发热性中性粒细胞减少患者的初始抗生素治疗方案。

Ceftazidime plus mezlocillin as initial antibiotic therapy in febrile neutropenic patients with haematological malignancy.

作者信息

Clough J V, Farrell I D, Wood M J, Leyland M J

出版信息

J Antimicrob Chemother. 1985 Mar;15(3):353-63. doi: 10.1093/jac/15.3.353.

DOI:10.1093/jac/15.3.353
PMID:3888943
Abstract

Sixty episodes of fever in neutropenic patients with haematological malignancy were treated with ceftazidime and mezlocillin. Improvement or temporary improvement was seen in 76% of patients with microbiologically or clinically documented infection. Fifty-seven per cent of episodes due to bacteraemia improved with the antibiotics. Escherichia coli and Staphylococcus aureus were the commonest pathogens isolated; bacteraemia due to Staph. epidermis was not encountered. The toxicity of ceftazidime plus mezlocillin was acceptable. Diarrhoea developed in 12% and a skin rash in 10%.

摘要

用头孢他啶和美洛西林治疗60例血液系统恶性肿瘤中性粒细胞减少患者的发热。在微生物学或临床确诊感染的患者中,76%有改善或暂时改善。由菌血症引起的发热发作,57%使用抗生素后得到改善。分离出的最常见病原体为大肠杆菌和金黄色葡萄球菌;未发现表皮葡萄球菌引起的菌血症。头孢他啶加美洛西林的毒性可以接受。12%的患者出现腹泻,10%出现皮疹。

相似文献

1
Ceftazidime plus mezlocillin as initial antibiotic therapy in febrile neutropenic patients with haematological malignancy.头孢他啶联合美洛西林作为血液系统恶性肿瘤发热性中性粒细胞减少患者的初始抗生素治疗方案。
J Antimicrob Chemother. 1985 Mar;15(3):353-63. doi: 10.1093/jac/15.3.353.
2
Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Am J Med. 1988 Jul 25;85(1A):36-43. doi: 10.1016/0002-9343(88)90173-8.
3
Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients.
Am J Med. 1988 Jul 25;85(1A):17-20. doi: 10.1016/0002-9343(88)90170-2.
4
Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.头孢吡肟与头孢他啶单药治疗实体瘤患儿发热伴中性粒细胞减少症的随机对照研究
Med Pediatr Oncol. 2001 Apr;36(4):434-41. doi: 10.1002/mpo.1107.
5
Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.用哌拉西林或头孢他啶联合阿米卡星抗生素组合治疗中性粒细胞减少的白血病患者发热性发作:一项随机研究的结果
Chemioterapia. 1988 Oct;7(5):323-6.
6
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.头孢吡肟+奈替米星或头孢他啶+阿米卡星或美罗培南单药治疗土耳其恶性肿瘤伴发热性中性粒细胞减少儿童的成本效益
J Chemother. 2001 Jun;13(3):281-7. doi: 10.1179/joc.2001.13.3.281.
7
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.头孢他啶和阿米卡星作为沙特阿拉伯中性粒细胞减少患者发热性发作的经验性治疗药物。
J Infect. 1992 Jul;25(1):11-9. doi: 10.1016/0163-4453(92)93393-5.
8
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.哌拉西林/他唑巴坦单药治疗与头孢他啶加阿米卡星联合治疗作为中性粒细胞减少癌症患者发热的经验性治疗。
Support Care Cancer. 1998 Jul;6(4):402-9. doi: 10.1007/s005200050184.
9
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].[哌拉西林-他唑巴坦与奈替米星联合治疗儿童发热性中性粒细胞减少症发作]
Med Mal Infect. 2005 Jun;35(6):357-62. doi: 10.1016/j.medmal.2005.04.004.
10
A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.一项关于妥布霉素联合替卡西林、妥布霉素联合头孢噻吩与替卡西林,或妥布霉素联合美洛西林治疗恶性肿瘤中性粒细胞减少患者感染的随机研究。
Am J Med Sci. 1984 Jan-Feb;287(1):16-23. doi: 10.1097/00000441-198401000-00004.